What are the main products of the manufacturer?

Main products include injection, medicine, western medicine, infusion, IV solution, parenteral solution, tablet, capsule, small volume injection, and inhalation.

What are the available payment terms?

The terms of payment include LC (Letter of Credit) and T/T (Telegraphic Transfer).

Paracetamol Injection GMP Manufacturer Medicine

Name: Paracetamol Injection GMP Manufacturer Medicine
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 852922315

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

Negotiable

20,000 Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

100ml: 1g

Suitable for

Elderly, Adult

State

Liquid

Shape

Injection

Type

Injection

Pharmaceutical Technology

Chemical Synthesis

Production Line

GMP Approved

Transport Package

Carton

Specification

80bottles/carton

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Key features

GMP Approved Production: Manufactured on GMP approved production lines ensuring international quality standards.

Full Automation Control: Production and logistics processes feature full automation and information control.

Clear Liquid Formulation: Product is a colorless clear or nearly colorless liquid suitable for injection.

Versatile Pain Relief: Treats light or moderate pain and serves as an auxiliary for severe pain management.

Fever Abatement: Effective treatment for reducing fever in adults and children.

70-Year Brand History: Shijiazhuang No. 4 Pharmaceutical Co., Ltd. has a 70-year history in the industry.

Global Market Reach: Products exported to over 80 countries across Asia, Americas, Europe, Africa, and Oceania.

Top 100 Enterprise: Ranked among China's top 100 pharmaceutical industry enterprises for consecutive years.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤18hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What is the recommended dosage for adults weighing over 50kg?

For adults and teenagers over 13 years old weighing over 50kg, the recommended dose is 1000mg every 6 hours or 650mg every 4 hours. The maximum single dose is 1000mg, and the daily maximum is 4000mg.

Q:How should the dosage be adjusted for children?

For children aged 2 to 12 years old, the recommended dose is 15mg/kg every 6 hours or 12.5mg/kg every 4 hours. The maximum single dose is 15mg/kg, and the daily maximum is 75mg/kg.

Q:Is the production process automated?

Yes, the production lines have achieved full automation control and information control in both the production and logistics processes.

Q:What is the minimum interval for successive administration?

The minimum interval for successive administration is 4 hours for all age groups and dosages.

Q:Does the dosage need adjustment when switching from oral to injection?

No, the dosage need not be adjusted when adults and teenagers change from oral Paracetamol to injection by phleboclysis.